中国当代医药2009，Vol.16Issue(13)：5-6,2.
恩替卡韦联合复方丹参滴丸治疗慢性乙型肝炎肝纤维化的临床研究
Observation of therapeutic effects of entecavir (ETV) combined with Danshen dripping pill(CDDP) in the treatment of chronic hepatitis B with hepatic fibrosis
范英丽 1袁勇 1冯志成1
作者信息
- 1. 海南医学院附属医院中医科,海南海口,570102
- 折叠
摘要
Abstract
Objective: To study the therapeutic effects of entecavir (ETV) combined with Danshen dripping pilI(CDDP) in a-eating Chronic hepatitis B with hepatic fibrosis. Methods: 60 cases of chronic hepatitis B with hepatic fibrosis were ran-domly divided into two groups: treatment group and control group. The treatment group was treated with ETV and CDDP while the control group was treated only with ETV for 6 months. Levels of HBV-DNA, HA, LN, PCⅢ and CⅣ were ob-served before and after treatment. Results: After therapy, the level of HBV-DNA, HA, LN, PC Ⅲ and CⅣ in two groups declined apparently. The levels of HA, LN, PCⅢ and CⅣ in the treated group declined apparently, compared with the control group, there was obviously difference (P<0.01). Conclusion: ETV combined with CDDP have obvious activity against HBV and meliorated Chronic hepatitis B with hepatic fibrosis.关键词
恩替卡韦/复方丹参滴丸/慢性乙肝/肝纤维化Key words
Entecavir (ETV)/ Compound Danshen dripping pilI(CDDP)/ Chronic hepatitis B/ Hepatic fibrosis分类
医药卫生引用本文复制引用
范英丽,袁勇,冯志成..恩替卡韦联合复方丹参滴丸治疗慢性乙型肝炎肝纤维化的临床研究[J].中国当代医药,2009,16(13):5-6,2.
